Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on July 29, 2026

Jul. 29, 2026

Tevogen Bio Holdings Inc. Becomes Tevogen Inc.

Indeterminate GlobeNewswire

Jul. 29, 2026

Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones

Indeterminate GlobeNewswire

Jul. 29, 2026

EDMO Expands System Intelligence Layer to Simplify Higher Education Admissions

Indeterminate GlobeNewswire

Jul. 29, 2026

Quantum Cyber Applauds President Trump's Drone Dominance Program and Supply Chain Framework, Reaffirms Commitment to On-Shore U.S. Manufacturing of Autonomous Systems

Indeterminate GlobeNewswire

Jul. 29, 2026

OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET

Indeterminate GlobeNewswire

Jul. 29, 2026

3D Systems’ Saudi Arabian Joint Venture NAMI Obtains Critical Military Manufacturing License for Local Defense Hardware Production

Indeterminate GlobeNewswire

Jul. 29, 2026

PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS

Indeterminate GlobeNewswire

Jul. 29, 2026

TG Therapeutics to Host Conference Call on Second Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

Jul. 29, 2026

Intermap Announces Definitive Agreement to Acquire PCI Geomatics Group

Indeterminate GlobeNewswire

Jul. 29, 2026

Nexera: KeepZone AI Enters into Exclusive Distribution Agreement for Fully Managed Autonomous Aerial Security Across Latin America

Indeterminate GlobeNewswire

Jul. 29, 2026

SPIRIT BLOCKCHAIN CAPITAL APPOINTS JUDY GALVEZ AS CHIEF FINANCIAL OFFICER AND PROVIDES CORPORATE UPDATE

Indeterminate GlobeNewswire

Jul. 29, 2026

Interest in Disability Insurance for Veterinarians Triples in 12 Months

Indeterminate GlobeNewswire

Jul. 29, 2026

uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update

Indeterminate GlobeNewswire

Jul. 29, 2026

Ocugen Announces that the U.S. Food and Drug Administration Has Granted OCU410 Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Geographic Atrophy, Secondary to Dry Age-Related Macular Degeneration

Indeterminate GlobeNewswire

Jul. 29, 2026

VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates

Indeterminate GlobeNewswire

Jul. 29, 2026

Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy

Indeterminate GlobeNewswire

Jul. 29, 2026

Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

Indeterminate GlobeNewswire

Jul. 29, 2026

VisionWave Files U.S. Non-Provisional Patent Application for DeepWave RF™, an AI-Powered Subsurface Sensing and Visualization Platform

Indeterminate GlobeNewswire

Jul. 29, 2026

Freehand Raises $75M to Scale AI Teams Managing Supply Chain Spend for Fortune 500 Companies

Indeterminate GlobeNewswire

Jul. 29, 2026

Atavistik Bio Appoints Habib Dable to its Board of Directors

Indeterminate GlobeNewswire